MICHAEL SCHEURER to Uterine Cervical Neoplasms
This is a "connection" page, showing publications MICHAEL SCHEURER has written about Uterine Cervical Neoplasms.
Connection Strength
4.671
-
Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia. Cancer Prev Res (Phila). 2023 08 01; 16(8):461-469.
Score: 0.691
-
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial. Trials. 2020 Oct 21; 21(1):872.
Score: 0.570
-
Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. Gynecol Oncol. 2018 02; 148(2):357-362.
Score: 0.469
-
Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study. J Immigr Minor Health. 2015 Jun; 17(3):704-12.
Score: 0.392
-
Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data. Cancer Causes Control. 2013 Nov; 24(11):1985-94.
Score: 0.346
-
Nativity differences in behaviors associated with high-risk HPV infection among Hispanic women in Houston, Texas, USA. J Immigr Minor Health. 2013 Aug; 15(4):836-41.
Score: 0.346
-
Associations between human herpesvirus-6, human papillomavirus and cervical cancer. Cancer Lett. 2013 Aug 09; 336(1):18-23.
Score: 0.339
-
Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S208-14.
Score: 0.230
-
Human papillomavirus-related cellular changes measured by cytometric analysis of DNA ploidy and chromatin texture. Cytometry B Clin Cytom. 2007 Sep; 72(5):324-31.
Score: 0.229
-
A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care. Sci Rep. 2023 11 21; 13(1):20397.
Score: 0.177
-
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System. Am J Prev Med. 2024 03; 66(3):540-547.
Score: 0.176
-
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings. Sci Transl Med. 2023 06 21; 15(701):eabn4768.
Score: 0.171
-
Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas. BMC Womens Health. 2021 01 06; 21(1):11.
Score: 0.145
-
Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes. Ethn Health. 2019 10; 24(7):804-815.
Score: 0.115
-
Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file. Cancer. 2014 Apr 15; 120(8):1203-11.
Score: 0.089
-
Optical technologies and molecular imaging for cervical neoplasia: a program project update. Gend Med. 2012 Feb; 9(1 Suppl):S7-24.
Score: 0.076
-
The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2865-71.
Score: 0.062
-
A novel method for semi-quantitative detection of HPV16 and HPV18 mRNA with a low-cost, open-source fluorimeter. Anal Bioanal Chem. 2025 Apr; 417(9):1765-1778.
Score: 0.048